In summary, our results suggest a major role for blueberry in protecting against MetS-associated CKD via a decrease in inflammation and most importantly, this study provides comparative evidence for the mechanism of action of BB, via inhibition of TLR4, and consequent attenuation of ERK and p38MAPK phosphorylation. The gene discussed is TLR4; the disease is metabolic syndrome.